Elucidating the specific pharmacological mechanism of action (MOA) of naturally transpiring compounds can be challenging. Whilst Tarselli et al. (60) developed the main de novo synthetic pathway to conolidine and showcased this naturally occurring compound properly suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic focus on https://howtouseconolidine80128.ageeksblog.com/36197721/conolidin-to-replace-traditional-painkillers-fundamentals-explained